Deng, Shengming

Roles of CA19-9 in pancreatic cancer: Biomarker, predictor and promoter

Luo, G., Jin, K., Deng, S., Cheng, H., Fan, Z., Gong, Y., Qian, Y., Huang, Q., Ni, Q., Liu, C., et al. (2021) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer

Pancreatic and Hepatic Oncology ResearchGlycosylation and Glycoproteins Research

Cited by 446

Molecular alterations and targeted therapy in pancreatic ductal adenocarcinoma

Qian, Y., Gong, Y., Fan, Z., Luo, G., Huang, Q., Deng, S., Cheng, H., Jin, K., Ni, Q., Yu, X., et al. (2020) · Journal of Hematology & Oncology

Pancreatic and Hepatic Oncology ResearchCancer Genomics and Diagnostics

Cited by 312

Increased vessel perfusion predicts the efficacy of immune checkpoint blockade

Zheng, X., Fang, Z., Liu, X., Deng, S., Zhou, P., Wang, X., Zhang, C., Yin, R., Hu, H., Chen, X., et al. (2018) · Journal of Clinical Investigation

Cancer Immunotherapy and BiomarkersMedical Imaging Techniques and Applications

Cited by 239